Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 61.3% in March

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 873,500 shares, a growth of 61.3% from the March 15th total of 541,500 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 8,735.0 days. Currently, 0.4% of the shares of the company are short sold.

Recordati Industria Chimica e Farmaceutica Stock Performance

RCDTF remained flat at $49.00 during midday trading on Friday. The stock has a fifty day simple moving average of $54.40 and a two-hundred day simple moving average of $53.68. The company has a market capitalization of $10.11 billion, a price-to-earnings ratio of 24.50 and a beta of 0.26. Recordati Industria Chimica e Farmaceutica has a one year low of $49.00 and a one year high of $55.00.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.